Iron status and the treatment of the anemia of prematurity.

Clin Perinatol

Department of Pediatrics, Steele Memorial Children's Research Center, 1501 N. Campbell Ave., PO # 24-5073, The University of Arizona, Tucson, AZ 85724-5073, USA.

Published: June 2002

Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0095-5108(02)00002-7DOI Listing

Publication Analysis

Top Keywords

rhepo therapy
12
iron status
8
therapy iron
8
rhepo
5
iron
4
status treatment
4
treatment anemia
4
anemia prematurity
4
prematurity unanswered
4
unanswered issues
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!